ArticleFrontiers in oncology2013

Epidermal growth factor receptor mutation status and rad51 determine the response of glioblastoma to multimodality therapy with cetuximab, temozolomide, and radiation.

Phyllis Rachelle Wachsberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.